Abstract
New interest in NAD biology has recently been revived, and enzymes involved in NAD biosynthetic pathways have been identified and characterized in mammals. Among them, nicotinamide phosphoribosyltransferase (Nampt) has drawn much attention in several different fields, including NAD biology, metabolism, and immunomodulatory response. The research history of this protein is peculiar and controversial, and its physiological function has been a matter of debate. Nampt has both intra- and extracellular forms in mammals. Intracellular Nampt (iNampt) is an essential enzyme in the NAD biosynthetic pathway starting from nicotinamide. On the other hand, an extracellular form of this protein has been reported to act as a cytokine named PBEF, an insulin-mimetic hormone named visfatin, or an extracellular NAD biosynthetic enzyme named eNampt. This review article summarizes the research history and reported functions of this unique protein and discusses the pathophysiological significance of Nampt as an NAD biosynthetic enzyme vs. a potential inflammatory cytokine in diverse biological contexts.
Keywords: Nampt, NAD biosynthesis, pancreatic β cells, metabolism, obesity, diabetes, aging, inflammatory cytokine, PBEF, visfatin
Current Pharmaceutical Design
Title: Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases
Volume: 15 Issue: 1
Author(s): Shin-ichiro Imai
Affiliation:
Keywords: Nampt, NAD biosynthesis, pancreatic β cells, metabolism, obesity, diabetes, aging, inflammatory cytokine, PBEF, visfatin
Abstract: New interest in NAD biology has recently been revived, and enzymes involved in NAD biosynthetic pathways have been identified and characterized in mammals. Among them, nicotinamide phosphoribosyltransferase (Nampt) has drawn much attention in several different fields, including NAD biology, metabolism, and immunomodulatory response. The research history of this protein is peculiar and controversial, and its physiological function has been a matter of debate. Nampt has both intra- and extracellular forms in mammals. Intracellular Nampt (iNampt) is an essential enzyme in the NAD biosynthetic pathway starting from nicotinamide. On the other hand, an extracellular form of this protein has been reported to act as a cytokine named PBEF, an insulin-mimetic hormone named visfatin, or an extracellular NAD biosynthetic enzyme named eNampt. This review article summarizes the research history and reported functions of this unique protein and discusses the pathophysiological significance of Nampt as an NAD biosynthetic enzyme vs. a potential inflammatory cytokine in diverse biological contexts.
Export Options
About this article
Cite this article as:
Imai Shin-ichiro, Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases, Current Pharmaceutical Design 2009; 15 (1) . https://dx.doi.org/10.2174/138161209787185814
DOI https://dx.doi.org/10.2174/138161209787185814 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neonatal Systemic Thrombosis: An Updated Overview
Current Vascular Pharmacology Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Breastfeeding Policy Development and the Prevention of Obesity
Current Pediatric Reviews QSAR Studies of PTP1B Inhibitors: Recent Advances and Perspectives
Current Medicinal Chemistry Neurotoxicity of Insecticides
Current Medicinal Chemistry Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Epigenetics and the Environmental Regulation of the Brain's Genome and its Function
Current Psychiatry Reviews Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Whole Embryo Culture: An Important Tool in Developmental Toxicology Today
Current Pharmaceutical Design Advancement in Obesity Management: Leptin and Adiponectin Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of Dietary Fats in Hypertension, Obesity and Insulin Resistance: A Comparative Study of Animals and Humans in Fetal and Adult Life
Current Nutrition & Food Science Understanding Gender Differences in Schizophrenia: A Review of the Literature
Current Psychiatry Reviews Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies
CNS & Neurological Disorders - Drug Targets Nifedipine Induced Gingival Hyperplasia in Pregnancy: A Case Report
Current Drug Safety Efficacy and Cardiovascular Safety of Sulfonylureas
Current Drug Safety The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology Cryopreservation of Ovarian Tissue: State of the Art in 2007
Current Women`s Health Reviews Long-Term Metabolic Consequences in Patients with a History of Gestational Diabetes
Current Pharmaceutical Design